This study gives further support for the importance of the immune system, ECM remodeling, and lipoproteins and cholesterol metabolism in the progression of OL to OSCC.
Abstract
Background
We assessed protein biomarkers expressed in oral leukoplakia (OL) that are associated with the risk of transformation into oral squamous cell carcinoma (OSCC).
Methods
Tissue sections of OL transforming into OSCC (leuko-ca), the corresponding OSCC and OL that did not progress to OSCC (leuko-nonca) were analyzed with global relative quantification to compare proteome profiles. Immunohistochemistry was performed to validate the expression of identified biomarkers.
Results
The top enriched biological pathways in OL transforming into OSCC within 5-26 months after diagnosis (short duration [SD]-leuko-ca) compared with leuko-nonca were pathways regulating remodeling of the extracellular matrix (ECM) and lipid and cholesterol metabolism/transport. Kininogen-1, apolipoprotein E (ApoE), collagen alpha-1 (XVIII) chain (COL18A1), sortilin, and perlecan were the most downregulated proteins, whereas EEF1D was the most upregulated in SD-leuko-ca compared with leuko-nonca. Immunohistochemistry confirmed the expression of kininogen-1, ApoE, perlecan, and EEF1D in OL and OSCC. In OSCC compared with leuko-ca, enriched biological pathways involved keratinocyte and epithelial differentiation and immune response regulation.
Conclusion
We identified biomarkers in OL that were associated with the risk of malignant transformation. Our study gives further support for the importance of the immune system, ECM remodeling, and lipoproteins and cholesterol metabolism in the progression of OL to OSCC.
BACKGROUND
Oral squamous cell carcinoma (OSCC) is an aggressive malignancy with limited prognostic biomarkers, in which metabolic reprogramming contributes to tumor progression. Amino acid transporters of the solute carrier family have emerged as key regulators of cancer biology; however, the role of solute carrier fam...
L. Q. R. de Oliveira, E. F. de Morais, Cintia Eliza Marques et al.· Journal of Oral Pathology &...· 0 citations
Oral squamous cell carcinoma (OSCC) is the most common malignancy of the oral cavity and is characterized by high invasiveness and a poor prognosis. Although a number of molecular biomarkers have been investigated, their clinical applications remain limited. Despite microtubule affinity-regulating kinase 4 (MARK4) havi...
Xin-Yue Zhang, Xiao-Xue Shen, Su-Jun Hu et al.· Oncology Letters· 0 citations
BACKGROUND
Oral squamous cell carcinoma (OSCC) remains a clinically heterogeneous malignancy with unsatisfactory long-term outcomes, particularly in patients with advanced disease and treatment resistance. Conventional clinicopathologic parameters incompletely capture the biological diversity of OSCC and provide limite...
Shi-Ling Dong, Jing-Jing Cheng, Shuan-Feng Xing et al.· The international journal of...· 0 citations
Oral Potential Malignant Lesions (OPMDs), including oral leukoplakia (OLK) and lichen planus (OLP), as well as Oral Squamous Cell Carcinoma (OSCC) are influenced by oral dysbiosis and might represent a disease continuum. Our hypothesis was that the oral salivary metabolomic reflects the association of those diseases. H...
L. Soiniemi, Eelis Hyvärinen, Jopi Mikkonen et al.· Clinical Oral Investigations· 0 citations
Porphyromonas gingivalis is a major periodontal pathogen increasingly associated with oral leukoplakia (OL) and oral squamous cell carcinoma (OSCC) due to its role in microbial dysbiosis and carcinogenesis. This study aimed to evaluate the relative abundance of P. gingivalis in healthy controls, OL, and OSCC patients a...
Ajay Kumar Verma, A. Narwal, M. Kamboj et al.· European Journal of Oral Sci...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.